Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyroid dysfunction during chronic amiodarone therapy.

S G Albert, L E Alves, E P Rose

    Journal of the American College of Cardiology
    |January 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Screening for Vitamin D Deficiency in Black Americans: Comparison of Total, Free, Bioavailable 25 Hydroxy Vitamin D Levels with Parathyroid Hormone Levels and Bone Mineral Density.

    The journal of nutrition, health & aging·2018
    Same author

    Low serum high-density lipoprotein cholesterol in obese subjects with normal serum triglycerides: the role of insulin resistance and inflammatory cytokines.

    Diabetes, obesity & metabolism·2007
    Same author

    Possible association between high-dose fluconazole and adrenal insufficiency in critically ill patients.

    Critical care medicine·2001
    Same author

    Effectiveness of a diabetes education program adapted for people with vision impairment.

    Diabetes care·2000
    Same author

    Delayed recovery of thyrotropin responsiveness after radioactive iodine therapy for hyperthyroidism.

    The American journal of the medical sciences·2000
    Same author

    Dose-response profile of acarbose in older subjects with type 2 diabetes.

    The American journal of the medical sciences·2000
    Same journal

    Aortic Valve Replacement in Women of Reproductive Age.

    Journal of the American College of Cardiology·2026
    Same journal

    Sudden Death in Cardio-Kidney-Metabolic Patients: Insights From FINE-HEART.

    Journal of the American College of Cardiology·2026
    Same journal

    Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial.

    Journal of the American College of Cardiology·2026
    Same journal

    Reframing Cardiometabolic Risk and Frailty Through Sarcopenic Obesity.

    Journal of the American College of Cardiology·2026
    Same journal

    Imaging-Derived Sarcopenic Obesity and Cardiovascular Outcomes: Insights Into Heart Failure Risk and Muscle Biology.

    Journal of the American College of Cardiology·2026
    Same journal

    The Measure of a Leader: Lessons in Leadership From Eugene Braunwald.

    Journal of the American College of Cardiology·2026
    See all related articles

    Long-term amiodarone therapy can cause thyroid dysfunction in nearly half of patients. Higher baseline TSH levels may indicate a risk for hypothyroidism, requiring careful L-thyroxine management.

    Area of Science:

    • Cardiology
    • Endocrinology
    • Pharmacology

    Background:

    • Amiodarone is an effective antiarrhythmic drug.
    • Long-term amiodarone use is associated with thyroid dysfunction.
    • Identifying patients at high risk for amiodarone-induced thyroid dysfunction is crucial.

    Purpose of the Study:

    • To analyze clinical and laboratory features of patients on long-term amiodarone therapy.
    • To identify predictors of amiodarone-induced thyroid dysfunction.
    • To evaluate management strategies for amiodarone-induced hypothyroidism.

    Main Methods:

    • Retrospective analysis of 99 patients on long-term amiodarone.
    • Monitoring of thyroid function tests (thyroxine, TSH, reverse T3).
    • Assessment of clinical and demographic factors.

    Related Experiment Videos

    Main Results:

    • 49% of patients developed thyroid dysfunction (hypothyroidism or hyperthyroidism).
    • Higher baseline TSH levels were observed in hypothyroid patients, but with overlap.
    • No significant differences in age, sex, amiodarone dose, or heart disease severity were found.
    • Thyroid dysfunction onset varied widely, from 1 month to 3 years.

    Conclusions:

    • Baseline TSH may be a risk factor for amiodarone-induced hypothyroidism.
    • Replacement therapy with L-thyroxine requires cautious dosage adjustment.
    • Normalization of TSH may necessitate excessively high L-thyroxine doses.